Health Check of the Healthcare Sector

What will you learn in this webinar?

Where the Indian and global healthcare sector stands currently?

What is its future outlook and how you, as an investor, can benefit from the growth of this sector?

Key learnings from this webinar

The COVID-19 pandemic has underscored the importance of healthcare and revealed the integral role that the sector plays in economic growth and development. Healthcare is a very vast and disparate sector with multiple sub-sectors. In this webinar, we will focus on decoding the global and Indian healthcare sectors and their future potential from an investment point of view.

• The Indian healthcare sector is currently valued at approximately USD 120 billion. It comprises several sub-sectors including pharmaceuticals, diagnostics, hospitals, medical devices, and CROs. Within this, hospitals are the largest segment and are witnessing the fastest growth.
• The lifecycle of a new drug, beginning from the molecule stage to the ‘go to market’ stage can be as long as 10 to 12 years. It can also cost anywhere between a few hundred million to a billion US dollars.
• Indian pharmaceuticals are at the forefront of the global healthcare ecosystem and will continue to be a leading export player. Currently, India imports nearly 65% of its starting material requirements primarily due to the relatively higher cost of production relative to China. However, with better infrastructure and higher government spends, the Indian API industry could potentially witness sharp growth.
• The top 5 European Union countries have a pharma market valued at approximately USD 180 million and a healthcare market valued at USD 1 trillion. The Chinese pharma market is valued at approximately USD 140 million and is the fastest growing market in the world. In comparison, the US healthcare market is valued at approximately USD 3 trillion and constitutes approximately 40-45% of the global healthcare market.